Editorial: Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low-dose rivaroxaban or the combination: Secondary analysis of the COMPASS randomised controlled trial.
| Autor: | Sehgal K; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Shung DL; Department of Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, USA.; Department of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, Connecticut, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Oct; Vol. 60 (7), pp. 961-962. Date of Electronic Publication: 2024 Sep 02. |
| DOI: | 10.1111/apt.18195 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Plný text